• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual August Micro-Cap Conference

    8/15/23 10:20:00 AM ET
    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ANEB alert in real time by email

    NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Sidoti & Company, LLC, Monday, August 14, 2023, Press release picture

    Presentation Schedule

    *All Times EST

    Wednesday, August 16, 2023 (Day 1)

    8:30-9:00

    Ohmyhome Ltd. (OMH)

    Hookipa Pharma Inc. (HOOK)

    *****

    9:15-9:45

    Loop Industries (LOOP)

    Zomedica Inc (ZOM)

    LEE Enterprises, Inc. (LEE)

    10:00-10:30

    Mativ Holdings, Inc. (MATV)

    DLH Holdings (DLHC)

    T2 Biosystems, Inc. (TTOO)

    10:45-11:15

    Near Intelligence (NIR)

    Surmodics Inc. (SRDX)

    L.B. Foster Company (FSTR)

    11:30-12:00

    IDACORP, Inc (IDA)

    Harvard Bioscience (HBIO)

    Citizens, Inc. (CIA)

    12:15-12:45

    Independence Contract Drilling (ICD)

    Personalis (PSNL)

    Silvercrest Asset Management Group Inc. (SAMG)

    1:00-1:30

    Ideal Power (IPWR)

    Anebulo Pharmaceuticals (ANEB)

    GEE Group (JOB)

    1:45-2:15

    Powell Industries, Inc. (POWL)

    MAIA Biotechnology, Inc. (MAIA)

    Rocky Mountain Chocolate (RMCF)

    2:30-3:00

    Innovative Solutions & Support (ISSC)

    Hillstream BioPharma, Inc. (HILS)

    Super League Gaming, Inc (SLGG)

    3:15-3:45

    Unisys Corporation (UIS)

    Markforged (MKFG)

    CaliberCos Inc. (CWD)

    4:00-4:30

    Sonim Technologies (SONM)

    KLX Energy Services Holdings (KLXE)

    Comstock Inc (LODE)

    1x1s Only

    (16th)

    DevvStream Inc. (DSTRF)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Paysign, Inc. (PAYS)

    *****

    *****

    *****

    *All Times EST

    Thursday, August 17, 2023 (Day 2)

    8:30-9:00

    *****

    AGBA Group (AGBA)

    *****

    9:15-9:45

    MtronPTI (MPTI)

    The Real Brokerage Inc (REAX)

    Splash Beverage Group (SBEV)

    10:00-10:30

    CLIQ Digital AG (CLIQ)

    LifeMD (LFMD)

    Mistras Group (MG)

    10:45-11:15

    Innovative Eyewear, Inc. (LUCY)

    CareCloud (CCLD)

    Granite Construction Inc. (GVA)

    11:30-12:00

    Shapeways (SHPW)

    Processa Pharmaceuticals (PCSA)

    Landsea Homes (LSEA)

    12:15-12:45

    *****

    Modular Medical (MODD)

    Sidus Space (SIDU)

    1:00-1:30

    Daktronics (DAKT)

    Kala Pharmaceuticals (KALA)

    Terran Orbital (LLAP)

    1:45-2:15

    SOBR Safe Inc. (SOBR)

    Xcel Brands (XELB)

    SYLA Technologies (SYT)

    2:30-3:00

    Intellicheck (IDN)

    Alpha Teknova, Inc. (TKNO)

    ClearOne, Inc. (CLRO)

    3:15-3:45

    AudioEye Inc (AEYE)

    Quince Therapeutics (QNCX)

    Astra Space (ASTR)

    4:00-4:30

    Iteris, Inc. (ITI)

    *****

    ARC Document Solutions (ARC)

    1x1s Only

    (17th)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Kelly Services, Inc. (KELYA)

    Paysign, Inc. (PAYS)

    Tennant Company (TNC)

    *****

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed a sister company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the nearly 25 years of experience Sidoti had as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 160 equities of which around 40 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 1,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC and Sidoti & Company, LLC



    View source version on accesswire.com:
    https://www.accesswire.com/774189/Sidoti-Events-LLCs-Virtual-August-Micro-Cap-Conference

    Get the next $ANEB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANEB
    $DLHC
    $HBIO
    $HOOK

    CompanyDatePrice TargetRatingAnalyst
    Unisys Corporation New
    $UIS
    12/10/2025Outperform
    William Blair
    Innovative Solutions and Support Inc.
    $ISSC
    12/5/2025$16.00Buy
    Craig Hallum
    Personalis Inc.
    $PSNL
    12/2/2025$11.00Equal-Weight
    Morgan Stanley
    Innovative Solutions and Support Inc.
    $ISSC
    11/21/2025$16.50Outperform
    Northland Capital
    Surmodics Inc.
    $SRDX
    11/14/2025Mkt Perform → Underperform
    Barrington Research
    IDACORP Inc.
    $IDA
    10/28/2025$129.00Equal Weight
    Wells Fargo
    IDACORP Inc.
    $IDA
    10/22/2025$157.00Buy
    BTIG Research
    Unisys Corporation New
    $UIS
    9/22/2025$4.00Hold
    Jefferies
    More analyst ratings

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates

    CHICAGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Ateganosine (THIO, 6-thio-2'-deoxyguanosine), a first-in-class telomere-targeting therapy under development by MAIA Biotechnology (NYSE:MAIA), appears to be gaining increasing attention in the oncology community as emerging clinical results continue to surpass expectations in advanced non-small cell lung cancer (NSCLC). With the therapy's Phase 2 trial ongoing and a pivotal Phase 3 program initiated this week, ateganosine is being closely watched as one of the most distinctive investigational approaches in solid-tumor treatment today. We believe that MAIA has positioned itself at the forefront of a new scientific category in oncology. To our know

    12/11/25 1:00:00 PM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer

    Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced the publication of one of the largest and most comprehensive patient cohorts to date from the landmark TRACERx study, in the journal Cell. The study, titled "Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction," demonstrates the clinical importance of ultrasensitive, tumor-informed molecular residual disease (MRD) testing in stage I to III non-small cell lung cancer (NSCLC). The study, led by Professor Charles Swanton at the Francis Crick Institute and University College London (UCL) in collaboration with Personalis, analyzed 431 NSCLC patients trac

    12/11/25 9:00:00 AM ET
    $PSNL
    Medical Specialities
    Health Care

    MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer

    Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in comparison to chemotherapy CHICAGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that the first patient has been dosed in the Company's THIO-104 Phase 3 pivotal trial evaluating the efficacy of ateganosine administered in sequence with a checkpoint inhibitor (CPI) as a third-line treatment for advanced non-small cell lung cancer (NSCLC). The multicenter, open-label trial of patients wh

    12/11/25 9:00:00 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Mink Brook Asset Management Llc bought $5,082 worth of shares (924 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    12/12/25 4:43:11 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Director Smith Stan bought $16,441 worth of shares (13,740 units at $1.20) (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    12/9/25 4:51:27 PM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Chief Executive Officer Vitoc Vlad bought $10,144 worth of shares (10,500 units at $0.97), increasing direct ownership by 1% to 831,421 units (SEC Form 4)

    4/A - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    12/4/25 7:31:28 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Mink Brook Asset Management Llc bought $5,082 worth of shares (924 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    12/12/25 4:43:11 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Director Smith Stan bought $16,441 worth of shares (13,740 units at $1.20) (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    12/9/25 4:51:27 PM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vice President, Operations Mckertcher Terry B sold $715,341 worth of shares (2,100 units at $340.64), decreasing direct ownership by 22% to 7,433 units (SEC Form 4)

    4 - POWELL INDUSTRIES INC (0000080420) (Issuer)

    12/8/25 4:11:19 PM ET
    $POWL
    Electrical Products
    Energy

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Unisys

    William Blair initiated coverage of Unisys with a rating of Outperform

    12/10/25 8:40:27 AM ET
    $UIS
    EDP Services
    Technology

    Craig Hallum initiated coverage on Innovative Aerosystems with a new price target

    Craig Hallum initiated coverage of Innovative Aerosystems with a rating of Buy and set a new price target of $16.00

    12/5/25 8:44:53 AM ET
    $ISSC
    EDP Services
    Technology

    Morgan Stanley resumed coverage on Personalis with a new price target

    Morgan Stanley resumed coverage of Personalis with a rating of Equal-Weight and set a new price target of $11.00

    12/2/25 8:29:48 AM ET
    $PSNL
    Medical Specialities
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    SEC Filings

    View All

    SEC Form 6-K filed by Ohmyhome Limited

    6-K - Ohmyhome Ltd (0001944902) (Filer)

    12/12/25 5:00:17 PM ET
    $OMH
    Real Estate
    Finance

    MAIA Biotechnology Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - MAIA Biotechnology, Inc. (0001878313) (Filer)

    12/11/25 4:15:36 PM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DLH Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DLH Holdings Corp. (0000785557) (Filer)

    12/10/25 4:30:27 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by HOOKIPA Pharma Inc.

    SC 13G/A - HOOKIPA Pharma Inc. (0001760542) (Subject)

    11/14/24 6:07:08 PM ET
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Surmodics Inc.

    SC 13G/A - SURMODICS INC (0000924717) (Subject)

    11/14/24 3:36:00 PM ET
    $SRDX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by IDACORP Inc.

    SC 13G/A - IDACORP INC (0001057877) (Subject)

    11/14/24 1:28:29 PM ET
    $IDA
    Electric Utilities: Central
    Utilities

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Leadership Updates

    Live Leadership Updates

    View All

    Mativ Announces Appointment of Seasoned Executive to Its Board of Directors

    Deborah Borg Brings 25+ Years of Corporate Leadership to Global Manufacturing Leader Mativ Holdings, Inc. (NYSE:MATV) announced today the appointment of Deborah Borg to its Board of Directors, effective immediately. In her role on the Mativ Board of Directors, Borg will serve on the Company's Compensation Committee and Nominating & Governance Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124104625/en/Deborah Borg, Mativ Board of Directors Borg is currently the Executive Vice President, Chief People & Culture Officer at International Flavors & Fragrances Inc. (NYSE:IFF), a global leader in food, beverage, health, b

    11/24/25 4:05:00 PM ET
    $IFF
    $MATV
    $SWM
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    Innovative Solutions & Support, Inc. d/b/a Innovative Aerosystems Appoints New Board Member

    Innovative Solutions & Support, Inc. d/b/a Innovative Aerosystems ("IA" or the "Company") (NASDAQ:ISSC) is pleased to announce the appointment of Richard Silfen to its Board of Directors ("Board") as an independent director, effective immediately. Mr. Silfen will stand for election at the Company's next annual meeting of shareholders or until his successor is duly elected and qualified or until his earlier, death, disqualification, resignation, or removal. With Mr. Silfen's appointment, the Board has been expanded to seven directors. Mr. Silfen is general counsel of Hildred Capital Management LLC, a New York City-based, healthcare-focused private equity firm that specializes in operationa

    10/28/25 4:05:00 PM ET
    $ISSC
    EDP Services
    Technology

    Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

    HOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. Mr. DeNelsky will also serve on the Board's Nominating and Governance Committee. "We are pleased to announce Steve as the newest member of our Board of Directors at such an important time for Harvard Bioscience," said John Duke, President & CEO. "His knowledge across the verticals we operate in, as well as his expertise in guiding life sciences companies on financial strategy will be invaluable as we move forward." "I'm honored to join the Board and lo

    9/9/25 7:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Financials

    Live finance-specific insights

    View All

    DLH Reports Fiscal 2025 Fourth Quarter Results

    ATLANTA, Dec. 10, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science research and development, today announced financial results for its fiscal fourth quarter ended September 30, 2025. Q4 Highlights: Revenue performance mixed as budgetary priorities continue to come into focus; solid revenue growth of 8.8% in National Security contract portfolio this quarter as compared to fiscal 2024 Q4.Delivered EBITDA of $6.6 million as investment in new business continued and company executed scaling initiatives at the end of the quarter and into fiscal 202

    12/10/25 4:15:00 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Innovative Aerosystems Announces Fourth Quarter and Full-Year 2025 Results Conference Call and Webcast Date

    Innovative Solutions & Support, Inc. d/b/a Innovative Aerosystems ("IA" or the "Company") (NASDAQ:ISSC), today announced that it will release fourth quarter and full-year 2025 results before the market opens on Thursday, December 18, 2025. A conference call will be held that same day at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of the Company's website at https://iascorp.com/investor-relations/. Individuals can also participate by teleconference dial-in. To listen to a live broadcast, go

    12/5/25 12:00:00 PM ET
    $ISSC
    EDP Services
    Technology

    DLH to Announce Fiscal 2025 Fourth Quarter Financial Results

    ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release financial results for the fiscal fourth quarter ended September 30, 2025 on December 10, 2025 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, December 11, 2025, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will

    11/20/25 1:37:22 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary